Ken Griffin Pds Biotechnology Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 4,800 shares of PDSB stock, worth $17,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,800
Previous 10,900
55.96%
Holding current value
$17,808
Previous $43,000
67.44%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PDSB
# of Institutions
80Shares Held
5.46MCall Options Held
155KPut Options Held
61.7K-
Vanguard Group Inc Valley Forge, PA1.41MShares$5.23 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$1.81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny381KShares$1.42 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA378KShares$1.4 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$1.28 Million0.18% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $106M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...